MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-91 Cr | ₹-60 Cr | ₹51 Cr | ₹11 Cr | ₹17 Cr |
What is the latest Cash Flow from Operating Activities ratio of MOREPEN LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹-91 Cr |
Mar2022 | ₹-60 Cr |
Mar2021 | ₹51 Cr |
Mar2020 | ₹11 Cr |
Mar2019 | ₹17 Cr |
How is Cash Flow from Operating Activities of MOREPEN LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-91 Cr | Negative | |
Mar2022 | ₹-60 Cr | Negative | |
Mar2021 | ₹51 Cr | 361.34 | |
Mar2020 | ₹11 Cr | -36.58 | |
Mar2019 | ₹17 Cr | - |
Compare Cash Flow from Operating Activities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,396.5 Cr | 3.2% | 2.8% | 73.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 3.2% |
2.8% |
73.2% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses